Lionel Carnot, MS, MBA, "is an Investment Partner at Bay City Capital and has been extensively involved in the firm's activities since he joined The Pritzker Organization in 2000. Prior to The Pritzker Organization, Mr. Carnot was a Principal at Oracle Partners, a healthcare hedge fund. He also held several positions in the pharmaceutical industry, including Product Manager for Prozac at Eli Lilly as well as several sales and marketing positions at Aventis. Mr. Carnot was also a strategy and management consultant to the biopharmaceutical industry while at Booz Allen & Hamilton and Accenture Strategic Services. Mr. Carnot is a member of the Board of Directors of Bioseek and Pathway Diagnostics and serves as an observer on the boards of Reliant Pharmaceuticals and Via Pharmaceuticals. Mr. Carnot holds an MBA with Distinction from INSEAD and an MS with honors in Molecular Biology from the University of Geneva." 
Resources and articles
Related Sourcewatch articles
- People, Pathway Diagnostics, accessed December 7, 2007.